Citation Impact

Citing Papers

Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
2001 StandoutScience
Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery
2007 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Treating prediabetes with metformin: systematic review and meta-analysis.
2009
Evaluation of Serum Procalcitonin in Patients with Systemic Inflammatory Response Syndrome with and without Infection
2009
Impact of interleukin-10, soluble CD25 and interferon-γ on the prognosis and early diagnosis of bacteremic systemic inflammatory response syndrome: a prospective observational study
2013
Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit
2002
Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System
2004
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes
2005
Understanding biofilm resistance to antibacterial agents
2003 Standout
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
2003 Standout
Lipopolysaccharide binding protein in a surgical intensive care unit: A marker of sepsis?*
2008
PROGNOSTIC VALUE OF INTERLEUKIN 6, PROCALCITONIN, AND C-REACTIVE PROTEIN LEVELS IN INTENSIVE CARE UNIT PATIENTS DURING FIRST INCREASE OF FEVER
2006
Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
2013 Standout
Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients
2007
Establishment of infection: lessons from a versatile opportunist
2000
Comparison of Fcγ receptor expression on neutrophils with procalcitonin for the diagnosis of sepsis in critically ill patients
2010
Time to Treatment and Mortality during Mandated Emergency Care for Sepsis
2017 Standout
Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial
2004
Characterization of mucoid Pseudomonas aeruginosa strains isolated from technical water systems
1995
Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery
2005
The metabolic syndrome
2010 Standout
Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections
2009
Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis
2005 Standout
Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations
2008
Procalcitonin Levels Predict Bacteremia in Patients With Community-Acquired Pneumonia
2010
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 StandoutNobel
Comparison of procalcitonin and C-reactive protein as markers of sepsis
2003
Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP – Results from the German competence network CAPNETZ
2009
Sepsis: a roadmap for future research
2015
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Severe Sepsis and Septic Shock
2013 Standout
Diagnostic and Prognostic Values of Admission Procalcitonin Levels in Community–Acquired Pneumonia in an Intensive Care Unit
2005
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
[25] Isolation and biochemical characterization of extracellular polymeric substances from Pseudomonas aeruginosa
2001
IL-6 as a keystone cytokine in health and disease
2015 Standout
Epidemiology and Prognostic Determinants of Bloodstream Infections in Surgical Intensive Care
2002
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study
2007
Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children
2016 Standout
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
The metabolic syndrome
2005 Standout
Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study
2006
The biofilm matrix
2010 Standout
Sepsis and septic shock
2018 Standout
Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study
2008
Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial
2009
Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome
2005
Mycobacterium tuberculosis Rv3406 Is a Type II Alkyl Sulfatase Capable of Sulfate Scavenging
2013 StandoutNobel
Granulocyte–Macrophage Colony-stimulating Factor to Reverse Sepsis-associated Immunosuppression
2009
Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis
2007
Novel crosslinking methods to design hydrogels
2002 Standout
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
2003 Standout
Serum miR-146a and miR-223 as potential new biomarkers for sepsis
2010
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Pseudomonas aeruginosa Disrupts Caenorhabditis elegans Iron Homeostasis, Causing a Hypoxic Response and Death
2013 StandoutNobel
Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis
2006
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
2011 Standout
Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study
2009
The acute respiratory distress syndrome
2012 Standout
Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis
2002
Intravenous Fluids and Acute Kidney Injury
2017 Standout
Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis
2004 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
Procalcitonin in the diagnosis of inflammation in intensive care units
2006
A review of the biochemistry of heavy metal biosorption by brown algae
2003 Standout
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations
2015 Standout
Procalcitonin Kinetics as a Prognostic Marker of Ventilator-associated Pneumonia
2004
Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia
2006
Inflammasome-regulated Cytokines Are Critical Mediators of Acute Lung Injury
2012
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
New Approaches to Sepsis: Molecular Diagnostics and Biomarkers
2012
Reliability of Procalcitonin as a Severity Marker in Critically Ill Patients with Inflammatory Response
2002
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
2002 Standout
Assessment of Clinical Criteria for Sepsis
2016 Standout
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
1996 Standout
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Implications of Rewiring Bacterial Quorum Sensing
2007 StandoutNobel
Procalcitonin: A Marker of Bacteraemia in SIRS
2003
Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock
2005
Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients
1991
Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection
1997
Alginates
1988
Diagnostic Efficacy and Prognostic Value of Serum Procalcitonin Concentration in Patients With Suspected Sepsis
2008
Determination of the uronic acid composition of alginates by high-performance liquid chromatography
1983
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
2011 Standout
Diagnostic and prognostic value of procalcitonin in patients with septic shock
2004
Meta-analysis: Metformin Treatment in Persons at Risk for Diabetes Mellitus
2008
The Metabolic Syndrome
2008 Standout
Insulin Oxidation and Determination at Carbon Electrodes
2005
Advanced Carbon Electrode Materials for Molecular Electrochemistry
2008 Standout
The purification and chemical characterisation of the alginate present in extracellular material produced by mucoid strains of Pseudomonas aeruginosa
1984
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock
2016 Standout
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Pathophysiology and Pharmacological Treatment of Insulin Resistance*
2000

Works of L. Vadas being referenced

Development of an Isotope Dilution Assay for Precise Determination of Insulin, C-peptide, and Proinsulin Levels in Non-diabetic and Type II Diabetic Individuals with Comparison to Immunoassay
1997
Metformin treatment leads to an increase in basal, but not insulin‐stimulated, glucose disposal in obese patients with impaired glucose tolerance
1999
Insulin Sensitivity in Obese Hypertensive Dyslipidemic Patients Treated with Enalapril or Atenolol
1995
Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection
2001
Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically Ill Patients Admitted with Suspected Sepsis
2001
A gas chromatographic method for the quantitative detemination of hexuronic acids in alginic acid
1981
GDPmannose dehydrogenase and biosynthesis of alginate-like polysaccharide in a mucoid strain of Pseudomonas aeruginosa
1983
Phenotypic differences among clinically isolated mucoid Pseudomonas aeruginosa strains
1982
Rankless by CCL
2026